Select Bibliography

Filter by any of these (after searching):

J. Clin. Oncol

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 70 items

Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial

Advani, Pooja P. , Ballman, Karla V. , Dockter, Travis J. ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Breast - N9831

Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling Methods

An, Ming-Wen , Han, Yu , Meyers, Jeffrey P. , Bogaerts, Jan ... - - J. Clin. Oncol - 2015

Manuscript - Secondary-not-in-original - Primary - GI - NCCTG-N9741

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303

Bartlett, Nancy L. , Wilson, Wyndham H. , Jung, Sin-Ho , Hsi, Eric D. ... - - J. Clin. Oncol - 2019

Manuscript - Primary - Primary - Lymphoma - CALGB-50303

Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

Basch, Ethan , Dueck, Amylou C. , Rogak, Lauren J. ... - - J. Clin. Oncol - 2018

Manuscript - Secondary-not-in-original - Primary - Health Outcome - N1048

Her2 gene expression and not Her2 amplification is predictive and prognostic in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB/SWOG 80405 (Alliance)

Battaglin, Francesca , Ou, Fang-Shu , Qu, Xueping ... - ASCO - J. Clin. Oncol - 2020

Abstract - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405

High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials

Berry, Donald A. , Ueno, Naoto T. , Johnson, Marcella M. ... - - J. Clin. Oncol - 2011

Manuscript - Secondary-not-in-original - Comprehensive - Breast - INT-0163

Impact of Young Age on Treatment Efficacy and Safety in Advanced Colorectal Cancer: A Pooled Analysis of Patients From Nine First-Line Phase III Chemotherapy Trials

Blanke, Charles D. , Bot, Brian M. , Thomas, David M. ... - - J. Clin. Oncol - 2011

Manuscript - Secondary-not-in-original - Comprehensive - GI - N9741

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance)

Boughey, Judy C. , Ballman, Karla V. , Hunt, Kelly K. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer

Brambilla, Elisabeth , Le Teuff, Gwénaël , Marguet, Sophie ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Respiratory - CALGB-9633

Endocrine Therapy With or Without Inhibition of Epidermal Growth Factor Receptor and Human Epidermal Growth Factor Receptor 2: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Fulvestrant With or Without Lapatinib for Postmenopausal Women With Hormone Receptor–Positive Advanced Breast Cancer—CALGB 40302 (Alliance)

Burstein, Harold J. , Cirrincione, Constance T. , Barry, William T. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Breast - CALGB-40302

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib

Carey, Lisa A. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - Breast - CALGB-40601

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial

Choueiri, Toni K. , Halabi, Susan , Sanford, Ben L. , Hahn, Olwen ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - GU - A031203

Incidence of Late Relapses in Patients With HER2-Positive Breast Cancer Receiving Adjuvant Trastuzumab: Combined Analysis of NCCTG N9831 (Alliance) and NRG Oncology/NSABP B-31

Chumsri, Saranya , Li, Zhuo , Serie, Daniel J. ... - - J. Clin. Oncol - 2019

Manuscript - Secondary-not-in-original - Primary - Breast - N9831 , NSABP B-31

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - GI - ACOSOG-Z9001

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

Devine, Steven M. , Owzar, Kouros , Blum, William , Mulkey, Flora ... - - J. Clin. Oncol - 2015

Manuscript - Primary - Primary - Transplant - CALGB-100103

Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)

Dickler, Maura N. , Barry, William T. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - Breast - CALGB-40503

Cancer and Leukemia Group B 90203 (Alliance): Radical Prostatectomy With or Without Neoadjuvant Chemohormonal Therapy in Localized, High-Risk Prostate Cancer

Eastham, James A. , Heller, Glenn , Halabi, Susan ... - - J. Clin. Oncol - 2020

Manuscript - Primary - Primary - GU - CALGB-90203

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - Respiratory - CALGB-30801

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Ellis, Matthew J. , Suman, Vera J. , Hoog, Jeremy ... - - J. Clin. Oncol - 2017

Manuscript - Secondary - Primary - Breast - ACOSOG-Z1031B

CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers

Enzinger, Peter C. , Burtness, Barbara Ann , Niedzwiecki, Donna ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - GI - CALGB-80403 , ECOG-1206

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

Fadelu, Temidayo , Zhang, Sui , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2018

Manuscript - Secondary - Primary - GI - CALGB-89803

Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell Lung Cancer

Fernando, Hiran C. , Landreneau, Rodney J. , Mandrekar, Sumithra J. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Respiratory - ACOSOG-Z4032

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

Freedman, Rachel A. , Foster, Jared C. , Seisler, Drew K. ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - Older Adult - A151527 , ACOSOG-Z1031 , ACOSOG-Z1041 , C8541 , C9344 , C9741 , CALGB-40101 , CALGB-40302 , CALGB-40502 , CALGB-40503 , CALGB-40601 , CALGB-40603 , CALGB-49907 , CALGB-9342 , CALGB-9840 , N89-30-52 , N9831

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)

Fuchs, Charles S. , Niedzwiecki, Donna , Mamon, Harvey J. ... - - J. Clin. Oncol - 2017

Manuscript - Primary - Primary - GI - CALGB-80101

Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)

Guercio, Brendan J. , Sato, Kaori , Niedzwiecki, Donna , Ye, Xing ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Prevention - C89803

Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

Halabi, Susan , Kelly, William Kevin , Ma, Hua , Zhou, Haojin ... - - J. Clin. Oncol - 2016

Manuscript - Secondary-not-in-original - Meta-Analysis - GU - CALGB-90601

Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

Halabi, Susan , Lin, Chen-Yen , Kelly, W. Kevin , Fizazi, Karim S. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary-not-in-original - Primary - GU - CALGB-90401

Topoisomerase IIα Amplification Does Not Predict Benefit From Dose-Intense Cyclophosphamide, Doxorubicin, and Fluorouracil Therapy in HER2-Amplified Early Breast Cancer: Results of CALGB 8541/150013

Harris, Lyndsay N. , Broadwater, Gloria , Abu-Khalaf, Maysa ... - - J. Clin. Oncol - 2009

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150013 , C8541

On-treatment changes of plasma protein biomarkers in CALGB/SWOG 80405 (Alliance)

Hatch, Ace J. , Ou, Fang-Shu , Zemla, Tyler , Liu , Star, Mark D. ... - ASCO GI - J. Clin. Oncol - 2019

Abstract - Secondary-not-in-original - Primary - GI - CALGB-80405

Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set

Hubbard, Joleen , Thomas, David M. , Yothers, Greg , Green, Erin ... - - J. Clin. Oncol - 2012

Manuscript - Secondary - Comprehensive - GI - ACCENT , CALGB-89803

Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor–Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance)

Hwang, E. Shelley , Hyslop, Terry , Hendrix, Laura H. ... - - J. Clin. Oncol - 2020

Manuscript - Primary - Primary - Breast - CALGB-40903

Mutational Analysis of Patients With Colorectal Cancer in CALGB/SWOG 80405 Identifies New Roles of Microsatellite Instability and Tumor Mutational Burden for Patient Outcome

Innocenti, Federico , Ou, Fang-Shu , Qu, Xueping , Zemla, Tyler J. ... - - J. Clin. Oncol - 2019

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-80405

Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial

Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki , Ballman, Karla ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011

Randomized, Double-Blind, Placebo-Controlled Phase III Trial Comparing Docetaxel and Prednisone With or Without Bevacizumab in Men With Metastatic Castration-Resistant Prostate Cancer: CALGB 90401

Kelly, William Kevin , Halabi, Susan , Carducci, Michael ... - - J. Clin. Oncol - 2012

Manuscript - Primary - Primary - GU - CALGB-90401

Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy With or Without Chemotherapy: A Phase III, Randomized, Double-Blind Trial (NCCTG-N09C6 [Alliance])

Leenstra, James L. , Miller, Robert C. , Qin, Rui ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N09C6

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)

Leonard, John P. , Jung, Sin-Ho , Johnson, Jeffrey ... - - J. Clin. Oncol - 2015

Manuscript - Primary - Primary - Lymphoma - CALGB-50401

Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study

Li, Zejuan , Herold, Tobias , He, Chunjiang , Valk, Peter J.M. ... - - J. Clin. Oncol - 2013

Manuscript - Secondary-not-in-original - Meta-Analysis - Leukemia - CALGB-19808 , CALGB-9222 , CALGB-9621 , CALGB-9710 , CALGB-9720

Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

Lichtman, Stuart M. , Cirrincione, Constance T. , Hurria, Arti ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Older Adult - A171201 , CALGB-49907

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

Loprinzi, Charles L. , Qin, Rui , Dakhil, Shaker R. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - Symptom Inter - N08CB

Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score

Marcucci, Guido , Yan, Pearlly , Maharry, Kati , Frankhouser, David ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Leuk Corr Sci - CALGB-10201 , CALGB-9420 , CALGB-9720 , CALGB-9621 , CALGB-19808

Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance)

Martin, Linda W. , D'Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Long-Term-Followup - Respiratory - C9761

Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy

Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean-Philippe ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Lymphoma - N0489

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials

Maurer, Matthew J. , Ghesquières, Hervé , Link, Brian K. ... - - J. Clin. Oncol - 2018

Manuscript - Primary - Primary - Lymphoma - A151814

Lenalidomide Maintenance After Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: A Meta-Analysis

McCarthy, Philip L. , Holstein, Sarah A. , Petrucci, Maria Teresa ... - - J. Clin. Oncol - 2017

Manuscript - Secondary-not-in-original - Primary - Myeloma - CALGB-100104

Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database

McCleary, Nadine J. , Meyerhardt, Jeffrey A. , Green, Erin ... - - J. Clin. Oncol - 2013

Manuscript - Secondary - Primary - GI - NCCTG-N0441

Phase I and Pharmacokinetic Study of Sorafenib in Patients With Hepatic or Renal Dysfunction: CALGB 60301

Miller, Antonius A. , Murry, Daryl J. , Owzar, Kouros ... - - J. Clin. Oncol - 2009

Manuscript - Primary - Primary - Experimental - CALGB-60301

Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer

Mittendorf, Elizabeth A. , Ballman, Karla V. , McCall, Linda M. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

Muss, Hyman B. , Polley, Mei-Yin C. , Berry, Donald A. , Liu, Heshan ... - - J. Clin. Oncol - 2019

Manuscript - Primary - Long-Term-Followup - Breast - CALGB-49907

Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance)

Niedzwiecki, Donna , Frankel, Wendy L. , Venook, Alan P. , Ye, Xing ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-150705 , C9581

Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. , Smith, Ellen M.L. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Symptom Inter - N08CB

Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology

Peppercorn, Jeffrey , Shapira, Iuliana , Collyar, Deborah ... - - J. Clin. Oncol - 2010

Manuscript - No-Endpoint - Comprehensive - Ethics - No Study Assigned

Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831

Perez, Edith A. , Romond, Edward H. , Suman, Vera J. ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Meta-Analysis - Breast - N9831

Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial

Perez, Edith A. , Thompson, E. Aubrey , Ballman, Karla V. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary - Primary - Breast - N9831

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial

Piccart-Gebhart, Martine , Holmes, Eileen , Baselga, José ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - Breast - N063D

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

Ready, Neal E. , Pang, Herbert H. , Gu, Lin , Otterson, Gregory A. ... - - J. Clin. Oncol - 2015

Manuscript - Primary - Primary - Respiratory - CALGB-30504

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials

Regan, Meredith M. , Francis, Prudence A. , Pagani, Olivia ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Ribi, Karin , Luo, Weixiu , Bernhard, Jürg , Francis, Prudence A. ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NCCTG N063H (Alliance)

Rugo, Hope S. , Barry, William T. , Moreno-Aspitia, Alvaro ... - - J. Clin. Oncol - 2015

Manuscript - Primary - Primary - Breast - CALGB-40502

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Saha, Poornima , Regan, Meredith M. , Pagani, Olivia ... - - J. Clin. Oncol - 2017

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)

Shapiro, Charles L. , Moriarty, James P. , Dusetzina, Stacie ... - - J. Clin. Oncol - 2017

Manuscript - Secondary - Primary - Symptom Inter - CALGB-70604

Resampling the N9741 Trial to Compare Tumor Dynamic Versus Conventional End Points in Randomized Phase II Trials

Sharma, Manish R. , Gray, Elizabeth , Goldberg, Richard M. ... - - J. Clin. Oncol - 2015

Manuscript - Secondary-not-in-original - Primary - GI - N9741

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

Shepherd, Frances A. , Domerg, Caroline , Hainaut, Pierre ... - - J. Clin. Oncol - 2013

Manuscript - Secondary-not-in-original - Comprehensive - Respiratory - CALGB-9633

Frailty and Adherence to Adjuvant Hormonal Therapy in Older Women With Breast Cancer: CALGB Protocol 369901

Sheppard, Vanessa B. , Faul, Leigh Anne , Luta, George ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Older Adult - CALGB-369901

Comparison of Doxorubicin and Cyclophosphamide Versus Single-Agent Paclitaxel As Adjuvant Therapy for Breast Cancer in Women With 0 to 3 Positive Axillary Nodes: CALGB 40101 (Alliance)

Shulman, Lawrence N. , Berry, Donald A. , Cirrincione, Constance T. ... - - J. Clin. Oncol - 2014

Manuscript - Secondary - Primary - Breast - CALGB-40101

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

Sikov, William M. , Berry, Donald A. , Perou, Charles M. ... - - J. Clin. Oncol - 2015

Manuscript - Primary - Primary - Breast - CALGB-40603

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

Sinicrope, Frank A. , Mahoney, Michelle R. , Smyrk, Thomas C. ... - - J. Clin. Oncol - 2013

Manuscript - Secondary-not-in-original - Primary - Correl Sci NOS - CALGB-89803 , N0147

Randomized Controlled Trial of Early Zoledronic Acid in Men With Castration-Sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance)

Smith, Matthew R. , Halabi, Susan , Ryan, Charles J. , Hussain, Arif ... - - J. Clin. Oncol - 2014

Manuscript - Primary - Primary - GU - CALGB-90202

Assessing the Impact of a Cooperative Group Trial on Breast Cancer Care in the Medicare Population

Soulos, Pamela R. , Yu, James B. , Roberts, Kenneth B. ... - - J. Clin. Oncol - 2012

Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-9343

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

Tsao, Ming-Sound , Marguet, Sophie , Le Teuff, Gwénaël ... - - J. Clin. Oncol - 2015

Manuscript - Secondary-not-in-original - Primary - Respiratory - CALGB-9633

A phase II study of pre- and post-operative gemcitabine and erlotinib plus pancreaticoduodenectomy (PD) for patients with resectable pancreatic ductal adenocarcinoma (PDAC): ACOSOG/ Alliance Z5041 Trial

Wei, Alice Chia-chi , Ou, Fang-Shu , Shi, Qian ... - ASCO - J. Clin. Oncol - 2018

Abstract - Primary - Primary - GI - ACOSOG-Z5041